In:
Pediatric pharmacology, Paediatrician Publishers LLC, Vol. 19, No. 4 ( 2022-10-04), p. 342-353
Abstract:
This article presents modern data on epidemiology, etiology, and clinical manifestations of mucopolysaccharidosis (MPS) type I in children. MPS develops due to deficiency of particular lysosomal enzyme which determines the disease type. The article considers in details disease's pathogenesis and classification. Evidence-based approaches to diagnosis (differential diagnosis included) are covered, moreover, special attention is paid to pathogenetic, symptomatic, and surgical treatment of MPS.
Type of Medium:
Online Resource
ISSN:
2500-3089
,
1727-5776
DOI:
10.15690/pf.v19i4.2443
Language:
Unknown
Publisher:
Paediatrician Publishers LLC
Publication Date:
2022
detail.hit.zdb_id:
3072851-4
Permalink